Abstract
Purpose
To assess the potential influencing effects of Dexmedetomidine on impaired lacrimal glands after high-dose radioiodine treatment (RAI).
Methods
Thirty-six rats were arbitrarily separated into 3 groups: Sham, RAI, and Dexmedetomidine. Dexmedetomidine group was given Dexmedetomidine and RAI, the Sham group was given the same millimeters of saline, and the RAI group was given RAI only. All forms of lacrimal glands, including harderian glands (HG), extraorbital (EG), and intraorbital (IG) lacrimal glands, were evaluated for immunohistochemical, histopathologic assessments and also for tissue cytokines, oxidant and antioxidant levels.
Results
Dexmedetomidine significantly ameliorated histopathologic changes such as periacinar fibrosis, acinar atrophy, lymphocytic infiltration, ductal proliferation, lipofuscin-like accumulation, and nucleus changes caused by RAI in all lacrimal gland forms (p < 0.05 for all of the parameters). However, periductal fibrosis was improved significantly only in EG (p = 0.049), and mast cell infiltration was improved significantly only in IG (p = 0.038) in Dexmedetomidine groups. There was a significant decrease in the elevated caspase-3 and TUNEL levels after RAI administration in the Dexmedetomidine group in all lacrimal gland forms (p < 0.05 for all parameters). Dexmedetomidine attenuated NF-kb, TNF-α, and IL-6 levels significantly diminished total oxidant status and raised total antioxidant status levels (p < 0.05 for all parameters).
Conclusions
The results of this study demonstrated that following RAI, Dexmedetomidine diminished inflammation, tissue cytokine levels, and apoptosis and ameliorated impaired histopathologic patterns of the lacrimal glands.
Similar content being viewed by others
References
Lee SL (2012) Radioactive iodine therapy. Curr Opin Endocrinol Diabetes Obes 19:420–428
Spitzweg C, Joba W, Schriever K et al (1999) Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 84:4178–4184
Bakheet SM, Hammami MM, Hemidan A et al (1998) Radioiodine secretion in tears. J Nucl Med 39:1452–1454
Solans R, Bosch JA, Galofré P et al (2001) Salivary and lacrimal gland disfunction (sicca syndrome) after radioiodine therapy. J Nuc Med 42:738–743
Sakahara H, Yamashita S, Suzuki K et al (2007) Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer. Ann Nucl Med 21:525–527
Kloos RT, Duvuuri V, Jhiang SM et al (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87:5817–5820
Zettinig G, Hanselmayer G, Fueger BJ et al (2002) Long-term impairment of the lacrimal glands after radioiodine therapy: a crosssectional study. Eur J Nucl Med Mol Imaging 29:1428–1432
Bonnema SJ, Hegedüs L (2012) Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 33(6):920–980
Koca G, Acar U, Atilgan HI et al (2013) Changes in conjunctival cytology and tear function tests with radioiodine treatment for hyperthyroidism. Ann Nucl Med 27:694–699
Dardalas I, Stamoula E, Rigopoulos P et al (2019) Dexmedetomidine effects in different experimental sepsis in vivo models. Eur J Pharmacol 856:172401
Kismet K, Sadic M, Bag YM, et al. (2016) Hepatoprotective effect of Dexmedetomidine against radioiodine toxicity in rats: evaluation of oxidative status and histopathological changes. Int Surg
Liang H, Liu HZ, Wang HB et al (2017) Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Inflamm Res 66(5):399–411
Smith TA, Kirkpatrick DR, Smith S et al (2017) Radioprotective agents to prevent cellular damage due to ionizing radiation. J Transl Med 15(1):232
Engelhard K, Werner C, Eberspächer E et al (2003) The effect of the alpha 2-agonist Dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96(2):524–531
Çınar S, Tümkaya L, Mercantepe T et al (2021) Can Dexmedetomidine be effective in the protection of radiotherapy-induced brain damage in the rat? Neurotox Res 39(4):1338–1351
Kucuk A, Yaylak F, Cavunt-Bayraktar A et al (2014) The protective effects of Dexmedetomidine on hepatic ischemia reperfusion injury. Bratisl Lek Listy 115(11):680–684
Kuru S, Barlas AM, Bozkirli B et al (2014) The protective effects of Dexmedetomidine on the liver against obstructive jaundice in rats. Acta Medica Mediterranea 30:1255–1262
Wang H, Hu B, Zou Y et al (2014) Dexmedetomidine premedication attenuates concanavalin A-induced hepatitis in mice. J Toxicol Sci 39(5):755–764
Damato BE, Allan D, Murray SB, Lee WR (1984) Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 68(9):674–680
Rios JD, Horikawa Y, Chen LL et al (2005) Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res 80(4):477–491
Koca G, Singar E, Akbulut A et al (2021) The effect of resveratrol on radioiodine therapy-associated lacrimal gland damage. Curr Eye Res 46(3):398–407
Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277–285
Erel O (2005) A new automated colorimetric method for measuring total oxidand status. Clin Biochem 38(12):1103–1111
Citrin D, Cotrim AP, Hyodo F et al (2010) Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 15(4):360–371
Li C, Wright MM, Jackson RM (2002) Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation. Exp Lung Res 28(5):373–389
McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312(3):159–163
Naziroğlu M, Simşek M, Kutlu M (2004) Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 42(5):511–517
Eren L, Naziroglu M, Demirdas A (2007) Protectice effects of lamotrigine, aripiprazole and escitalopramon depression induced oxidative stress in ratbrain. Neurochem Res 32(7):1188–1195
Baysal Z, Togrul T, Aksoy N et al (2009) Evaluation of total oxidative and antioxidative status in pediatric patients undergoing laparoscopic surgery. J Pediatr Surg 44(7):1367–1370
Jones BM, Kwok CC, Kung AW (1999) Effect of radioactive iodine therapy on cytokine production in Graves’ disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metab 84:4106–4110
Williams RM, Singh J, Sharkey KA (1994) Innervation and mast cells of the rat exorbital lacrimal gland: the effect of age. J Auton Nerv Syst 47:95–108
Burd PR, Rogers HW, Gordon JR et al (1989) Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245–257
Gordon JR, Galli SJ (1990) Mast cells as a source of both preformed and immunologically inducible TNFalpha/cachectin. Nature 346:274–276
Gordon JR, Galli SJ (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med. 174:103–107
Jaatinen P, Koistinaho J, Hervonen A (1989) Age-related morphometric and histochemical features of rat sympathetic neurons. Adv Exp Med Biol 266:61–72
Cuervo AM, Dice JF (2000) When lysosomes get old. Exp Gerontol 35:119–131
Cekic B, Geze S, Ozkan G et al (2014) The effect of Dexmedetomidine on oxidative stress during pneumoperitoneum. Biomed Res Int 2014:760323
Shalini S, Dorstyn L, Dawar S et al (2015) Old, new and emerging functions of caspases. Cell Death Differ 22:526–539
Pordanjani SM, Hosseinimehr SJ (2016) The role of NF-kb inhibitors in cell response to radiation. Curr Med Chem 23(34):3951–3963
Yumusak N, Sadic M, Yucel G et al (2018) Apoptosis and cell proliferation in short-term and long-term effects of radioiodine-131-induced kidney damage: an experimental and immunohistochemical study. Nucl Med Commun 39(2):131–139
Kluck RM, Bossy-Wetzel E, Green DR et al (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132–1136
Yang J, Liu X, Bhalla K et al (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129–1132
Fan Y, Chiu JF, Liu J et al (2018) Resveratrol induces autophagy-dependent apoptosis in HL-60 cells. BMC Cancer 18(1):581
Susin SA, Zamzami N, Castedo M et al (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331–1341
Xiang J, Chao DT, Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 93(25):14559–14563
Funding
Declared none.
Author information
Authors and Affiliations
Contributions
Singar, Akbulut wrote the main manuscript; Yazıhan, Yumusak and Demir prepared figures; Singar, Koca, Korkmaz, Burcu and Atılgan prepared the study, all authors reviewed the manuscript.
Corresponding author
Ethics declarations
Compliance with ethical standards
All procedures on animals were carried out by the Animal Ethics Committee. The Laboratory Animal Care Committee of the University of Health Sciences Ankara Training and Research Hospital reviewed and approved the experimental protocol (Report no:19.03.2020/609).
Conflict of interest
The authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Şingar, E., Akbulut, A., Koca, G. et al. The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment. Int Ophthalmol 44, 115 (2024). https://doi.org/10.1007/s10792-024-03052-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-03052-6